Aura Renewable Acquisiti... Share Discussion Threads

[clarky5150] 27/3/2008 08:51

...2.75. Damn, wished i had topped up now!

[clarky5150] 27/3/2008 08:42

...make that 2.5p.

[clarky5150] 27/3/2008 08:41

Was that spike down earlier this week the bottom??
Glass half full person that i am reads the following recent statement by CEO:

'Chief executive Huw Jones insisted last night that the firm, which is seeking a merger with a cash-rich group, was pleased with the progress it was making, and dismissed the share slide, on light trading, as "irrelevant".'

as positive suggesting to me that
a) There may well be someone close to a buyout or even a few companies running the slide rule over this.

or

b) As yet no interest but safe knowledge that the product is good enough to continue development and will comfortably attract a suitor before long.

Anyhow up 2p today and a mighty 150% higher than recent lows. Well done all you bottom fishers (if anyone actually got chance!) on a fantastic short term return with more to come me thinks.

[n_w_b] 25/3/2008 19:48

Bit of a stitch up. Tried to buy a bulk, but max number available online to buy was 500 throughout the whole time it was negative.

From there being loads of stock to buy and no stock to sell, its conpletely changed.

Something smells on this one!

[mike111d] 25/3/2008 19:20

Most odd behaviour considering the very light volumes, perhaps they were hoping to hit a few stop losses.

[timely] 25/3/2008 12:29

I am kicking myself now as could have doubled my money this morning. Typical!!

[chesty1] 25/3/2008 10:00

Well if anyone was able to bottom fish here could have made a packet....

Just watching & not holding unfortunately....

Well done any bottom fishers.

[chesty1] 25/3/2008 10:00

....

double post...DOH..!

[n_w_b] 21/3/2008 08:47

What a sad story; all the products are valued at nothing.

????

Ardana chief executive plays down new share-price low as 'irrelevant'


ARDANA plunged to a fresh low of 9p yesterday, valuing the Edinburgh-based pharmaceutical company at roughly its bank balance.

Chief executive Huw Jones insisted last night that the firm, which is seeking a merger with a cash-rich group, was pleased with the progress it was making, and dismissed the share slide, on light trading, as "irrelevant".

Ardana dropped 2p to 9p, the company is now valued at just under £5.9 million, compared with its cash pile of £6.1m last month.

[dr biotech] 13/3/2008 14:00

Cash in the bank is 6m. This has to be one of the worst run bios ever floated in the UK, and thats saying something.

[clarky5150] 13/3/2008 12:59

So another down day. 14 more and its game over! When does this become reward outweighing risk i wonder?

[n_w_b] 23/2/2008 17:13

Whether to buy?

It's clearly being shorted inorder to pick up cheaper, but at what price to buy.

Current Market cap : 12.12m
Total shares : 65.5m

Cash in bank : 6m
Cash in the Bank per share, excluding Assets : 9.1p

So currently, if someone was going to make an offer at the current price it would only cost them 6.12m.


So whom would be interested?



There's clearly a lot of value in it's portfolio. Should be worth a lot more than 6m? It paid 4.2m for the right to sell Emselex in the UK, let alone the rest of it's pipleline.

??

[goodgrief] 22/2/2008 17:48

Most biotechs are just a gamble. Name me any in the UK market that aren't!?

A gamble that the products in their pipeline don't fail at any phase of testing and a gamble that they'll be able to sign deals for those products.

[vision88] 22/2/2008 17:10

When to invest? basics does it have a good cash flow, if no then its a pure gamble, that may or may not pay off.

This on the face of it was a pure gamble that now is seen not to have paid off,sale of the company looks to be its only route to some cash recovery.

vision88

[february 30th] 20/2/2008 20:57

Well, I did once briefly consider buying it. There seemed to be a lot of voices suggesting it was going in the right direction. But it seems that the cash demands of the business were very high, with no immediate prospect of profitability.

[drewz] 20/2/2008 18:44

Not one of the Independent's best tips then (BUY Ardana at 125p, I seem to recall)!

[february 30th] 20/2/2008 15:26

Why didn't they sort out their funding issues when the price was over a pound? Was a placing at that level, or even at big discount from that, impossible? And to leave the issue open, in the public domain, is surely asking for the share price to be pushed down.

[dr biotech] 20/2/2008 12:09

So then after talks progressing well etc for many months management throw in the towel. I can't see this one ending happily unfortunately


LONDON (Thomson Financial) - Ardana PLC, the Scottish-based pharmaceutical
company, said it is seeking to sell or merge the company in order to increase
the shareholder value of its product pipeline.
The decision to sell comes after a strategic review in December which
concluded the company had to focus efforts and resources on products that are
closer to the market.
The company has experienced a difficult year, with CEO Maureen Lindsay
stepping down before poor half year results in October. At that time, the
company said it did not have enough cash to continue with its plans for the next
12 months.
Ardana emphasised that it will scale back its activities to save cash and
will halt further development on its Tevelerix LA cancer product and its
testosterone cream.
The company advised in a separate management statement that cash and
equivalents at the end of January 2008 was 6.1 mln stg, compared with 17.4 mln
last year.
Cash burn at the end of last year was 10.4 mln stg compared with 9.7 mln at
the end of December 2006.
Ardana CEO Huw Jones said: "Ardana's strength is its portfolio ...
Successful execution of our strategy to sell or merge the Company will enable
the potential in the pipeline to be maximized".

[e-mail]
jh1/ejp

COPYRIGHT

[southwards] 08/2/2008 18:19

this is typical of a fundraising going on in the background. i wouldn't be at all surprised to hear of such news in the short term.

am watching VERY closely but will only buy in once the uncertainty is over. better to buy at a premium when the uncertainty has cleared and the share price is on the way up rather than catch it pre-fundraising. been there too many times in the past to fall for that one.

[gnomet2] 05/2/2008 15:43

It got stamped on pretty quick!

[entj] 05/2/2008 12:09

Something stirring in the undergrowth?

[goodgrief] 10/1/2008 12:14

Not much loved in today's markets...

US regulatory boost for Ardana



Ardana, the small-cap Scottish pharmaceutical company, yesterday said it had agreed a development programme with the US Food & Drug Administration for its Teverelix product to treat endometriosis, a condition that affects some 89 million women around the world.

The so-called pre-IND agreement sets out the FDA's requirements for the testing of the new drug, and Ardana said it plans to make a formal application for testing this year, with phase II clinical trials to follow.

Shares in the Edinburgh-based company, which specialises in human reproductive health, climbed 0.5p to 39.5p after the announcement yesterday.

Endometriosis arises in pre-menopausal women when the lining of the womb grows outside the uterus, typically in the pelvic cavity. The condition can cause severe and chronic pain, infertility and heavy periods.

In 2004, it was estimated that there were approximately 17 million cases of endometriosis in the seven major pharmaceutical markets - the US, Japan, France, Germany, Italy, Spain and the UK.

It is well documented that endometriosis is a hormone-sensitive condition, and Ardana said yesterday that two previous phase I clinical studies have shown Teverelix can reduce oestrogen levels rapidly.

Dr Huw Jones, Ardana's chief executive, said: "We are encouraged by the feedback we have received from the FDA on the way forward for Teverelix in endometriosis.

"There is, in our view, a high unmet medical need for an effective treatment for endometriosis."

Teverelix is also being developed to treat the prostate enlargement condition BPH.

[dr biotech] 02/1/2008 10:04

This bio seems to sum up the whole sector. Management promise a deal to take things forward, nothing occurs and the share price dives. Might be worth a punt now, but I can wait for news